These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 17382919)

  • 1. The role of protein kinases in pancreatic carcinogenesis.
    Ammerpohl O; Kalthoff H
    Clin Chim Acta; 2007 May; 381(1):56-62. PubMed ID: 17382919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
    Xue A; Xue M; Jackson C; Smith RC
    Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gamma-aminobutyric acid (GABA) stimulates pancreatic cancer growth through overexpressing GABAA receptor pi subunit.
    Takehara A; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Nakamura Y; Nakagawa H
    Cancer Res; 2007 Oct; 67(20):9704-12. PubMed ID: 17942900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia.
    Badea L; Herlea V; Dima SO; Dumitrascu T; Popescu I
    Hepatogastroenterology; 2008; 55(88):2016-27. PubMed ID: 19260470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
    Chung JC; Oh MJ; Choi SH; Bae CD
    ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma.
    Liang JJ; Wang H; Rashid A; Tan TH; Hwang RF; Hamilton SR; Abbruzzese JL; Evans DB; Wang H
    Clin Cancer Res; 2008 Nov; 14(21):7043-9. PubMed ID: 18981001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
    Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
    J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BGLAP is expressed in pancreatic cancer cells and increases their growth and invasion.
    Kayed H; Bekasi S; Keleg S; Michalski CW; Giese T; Friess H; Kleeff J
    Mol Cancer; 2007 Dec; 6():83. PubMed ID: 18163903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
    Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
    Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic changes of pituitary tumor-derived transforming gene 1 in pancreatic cancer.
    Zhang ML; Lu S; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):313-7. PubMed ID: 18522889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of asparagine synthetase under glucose-deprived conditions protects pancreatic cancer cells from apoptosis induced by glucose deprivation and cisplatin.
    Cui H; Darmanin S; Natsuisaka M; Kondo T; Asaka M; Shindoh M; Higashino F; Hamuro J; Okada F; Kobayashi M; Nakagawa K; Koide H; Kobayashi M
    Cancer Res; 2007 Apr; 67(7):3345-55. PubMed ID: 17409444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of multi-SH3 domain-containing protein interactome in pancreatic cancer: a yeast two-hybrid approach.
    Thalappilly S; Suliman M; Gayet O; Soubeyran P; Hermant A; Lecine P; Iovanna JL; Dusetti NJ
    Proteomics; 2008 Aug; 8(15):3071-81. PubMed ID: 18654987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.
    Uhland K; Siphos B; Arkona C; Schuster M; Petri B; Steinmetzer P; Mueller F; Schweinitz A; Steinmetzer T; Van De Locht A
    Int J Oncol; 2009 Aug; 35(2):347-57. PubMed ID: 19578749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of C2orf18, termed ANT2BP (ANT2-binding protein), as one of the key molecules involved in pancreatic carcinogenesis.
    Kashiwaya K; Hosokawa M; Eguchi H; Ohigashi H; Ishikawa O; Shinomura Y; Nakamura Y; Nakagawa H
    Cancer Sci; 2009 Mar; 100(3):457-64. PubMed ID: 19154410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia.
    Kojima K; Vickers SM; Adsay NV; Jhala NC; Kim HG; Schoeb TR; Grizzle WE; Klug CA
    Cancer Res; 2007 Sep; 67(17):8121-30. PubMed ID: 17804724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of growth factors and the urokinase-type plasminogen activator system in pancreatic ductal adenocarcinoma.
    Xue A; Scarlett CJ; Jackson CJ; Allen BJ; Smith RC
    Pancreas; 2008 Mar; 36(2):160-7. PubMed ID: 18376307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of ONECUT1 expression in human pancreatic cancer cells.
    Jiang X; Zhang W; Kayed H; Zheng P; Giese NA; Friess H; Kleeff J
    Oncol Rep; 2008 Jan; 19(1):157-63. PubMed ID: 18097590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.
    Dancer J; Takei H; Ro JY; Lowery-Nordberg M
    Oncol Rep; 2007 Jul; 18(1):151-5. PubMed ID: 17549361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-1 is a novel functional receptor for tissue plasminogen activator in pancreatic cancer.
    Roda O; Ortiz-Zapater E; Martínez-Bosch N; Gutiérrez-Gallego R; Vila-Perelló M; Ampurdanés C; Gabius HJ; André S; Andreu D; Real FX; Navarro P
    Gastroenterology; 2009 Apr; 136(4):1379-90, e1-5. PubMed ID: 19171142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.